Author(s): Zeena Fernandes, Dattatreya K S, Sahana D Kulkarni

Email(s): Email ID Not Available

DOI: 10.52711/0974-360X.2024.00449   

Address: Zeena Fernandes*, Dattatreya K S, Sahana D Kulkarni
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, (NGSMIPS), Department of Pharmacology, Mangaluru, 575018, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 6,     Year - 2024

Objective: The study purpose is to identify the potential of Citrus limon in the pharmacotherapy of Alzheimer’s disease (AD) via a network pharmacology approach. Methods: ChEBI database was used to retrieve structural information of C. limon bioactive phytoconstituents. Targets of these compounds were selected by Swiss Target Prediction. Potential targets of AD were downloaded from the DisGeNet database. Phytoconstituents were predicted for their drug-likeness score, probable side effects, and ADMET profile. The interaction between compounds, proteins and pathways were interpreted using edge count from Cytoscape. For the docking research, Maestro software was used. Results: Seven phytoconstituents of C. limon have been found to have the ability to modify pathogenic protein molecules involved in AD. Theophylline exhibited the highest drug-likeness score and the most interacted compound with proteins involved in Alzheimer's disease. In addition, metabolic pathway was majorly regulated. Conclusion: Hence, theophylline was identified as an important AD constituent, which modulated majority of AD proteins.

Cite this article:
Zeena Fernandes, Dattatreya K S, Sahana D Kulkarni. Integration of the Computational Tools to Decode the Mode of Action of Citrus limon against Alzheimer’s Disease. Research Journal of Pharmacy and Technology. 2024; 17(6):2863-8. doi: 10.52711/0974-360X.2024.00449

Zeena Fernandes, Dattatreya K S, Sahana D Kulkarni. Integration of the Computational Tools to Decode the Mode of Action of Citrus limon against Alzheimer’s Disease. Research Journal of Pharmacy and Technology. 2024; 17(6):2863-8. doi: 10.52711/0974-360X.2024.00449   Available on:

1.    Dalal PS et al.Alzheimer Disease: A Review. International Journal of Research Publication and Reviews. 2021; 2(11): 240-241.
2.    Hardy J, et al. Pathways to Alzheimer’s disease. J. Intern. Med. 2014; 275(3): 296–303.
3.    Mamelak M. Alzheimer’s disease, oxidative stress and gammahydroxybutyrate. Vol. 28, Neurobiol Aging. 2007; 28(9): 1340-60. doi: 10.1016/j.neurobiolaging.2006.06.008
4.    Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011; 1(1): 2-24.doi: 10.1101/cshperspect.a006189
5.    Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;  4:177. doi: 10.3389/fphar.2013.00177.
6.    Talevi A. Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective. Front Pharmacol. 2015; 6:205. doi: 10.3389/fphar.2015.00205.
7.    Petrovska BB. Historical review of medicinal plants’ usage. Pharmacognosy Reviews. 2012; 6(11):1-5.
8.    Afrin D, et al. Characterization of citrus bacterial spot bacteria through biochemical approaches and its control measures. J. Sylhet Agril. Univ. 2016; 3(2): 315–23.
9.    Paw M, Begum T, Gogoi R, et al. Chemical composition of Citrus limon L. Burmf peel essential oil from North East India. Journal of Essential Oil Bearing Plants. 2020; 23(2): 337-44.
10.    Turner T, Burri BJ. Potential nutritional benefits of current citrus consumption. Agric. 2013; 3(1): 170–87.
11.    Hopkins AL. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11): 682–90.
12.    Zhang GB, Li QY, Chen QL, Su SB. Network pharmacology: a new approach for chinese herbal medicine research. Evid Based Complement Alternat Med. 2013; 2013: 621423. doi: 10.1155/2013/621423.
13.    De Matos P, Alcántara R, Dekker A, et al. Chemical entities of biological interest: an update. Nucleic Acids Research. 2010;38(suppl_1):249-54.
14.    Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Research. 2016; 44(D1): D1202-13.
15.    Gfeller D, Grosdidier A, Wirth M, et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic acids Research. 2014; 42(W1):W32-8.
16.    Pinero J, Queralt-Rosinach N, Bravo A, et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database. 2015; 2015: bav028.
17.    Kalita J, Chetia D, Rudrapal M. Molecular docking, drug-likeness studies and ADMET prediction of quinoline imines for antimalarial activity. J. Med. Chem. Drug Des. 2019; 2(1): 1-7.
18.    Ivanov SM, et al. ADVERPred-Web Service for Prediction of Adverse Effects of Drugs. J Chem Inf Model. 2018; 58(1): 8-11. doi: 10.1021/acs.jcim.7b00568.
19.    Yang H, Lou C, Sun L, et al. AdmetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019; 35(6): 1067–9.
20.    Von Mering C, Huynen M, Jaeggi D, et al. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31(1): 258–61.
21.    Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11): 2498-504.doi: 10.1101/gr.1239303.
22.    Khanal P, et al. Network pharmacology-based assessment to elucidate the molecular mechanism of anti-diabetic action of Tinospora cordifolia. Clinical Phytoscience. 2019; 5: 1-9.
23.    Omar AM, et al. Docking and Molecular Dynamic Investigations of Phenylspirodrimanes as Cannabinoid Receptor-2 Agonists. Molecules. 2022; 28(1): 44. doi: 10.3390/molecules28010044.
24.    Burley SK, et al. RCSB Protein Data Bank ( delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Res. 2023; 51: 488-508. doi: 10.1093/nar/gkac1077.
25.    Agatonovic-Kustrin S, Kettle C, Morton DW. A molecular approach in drug development for Alzheimer’s disease. Biomedicine and Pharmacotherapy. 2018; 106: 553-65.
26.    Libro R, et al. Natural phytochemicals in the treatment and prevention of dementia: An overview. Molecules. 2016; 21(4): 518.
27.    Yousaf M, et al. Recent synthetic approaches towards biologically potent derivatives/analogues of theophylline. Journal of Heterocyclic Chemistry. 2018; 55(11): 2447-79.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available